Laura Mangiavini | Regenerative Medicine: Translating Science Into Care | Milan Longevity Summit 26

*Mesenchymal Stem Cells in Knee Osteoarthritis* Can stem cells change the way we treat osteoarthritis? In this session from *Regenerative Medicine: Translating Science Into Care* at the *Milan Longevity Summit 2026*, *Professor Laura Mangiavini* explores the potential of mesenchymal stem cells in treating knee osteoarthritis, one of the most common causes of pain and reduced mobility with age. Rather than focusing solely on managing symptoms, regenerative approaches aim to influence the biological environment of the joint itself. Professor Mangiavini examines the science behind mesenchymal stem cells, their interaction with damaged tissues and inflammation, and their potential role within the evolving treatment landscape for osteoarthritis. Professor Laura Mangiavini is Associate Professor and an orthopaedic specialist at *IRCCS Ospedale Galeazzi-Sant'Ambrogio*, where her clinical and research work focuses on musculoskeletal disorders, osteoarthritis, cartilage biology, and regenerative medicine. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a *One Health* perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. *Learn more about the Milan Longevity Summit:* https://www.milanlongevitysummit.org/it/speakers26/laura-mangiavini #MilanLongevitySummit #Longevity #OneHealth #LauraMangiavini #StemCells #Osteoarthritis #KneeHealth #RegenerativeMedicine #HealthyAgeing #Mobility